title: Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study.
authors.affiliation: Laboratoire d'Histocompatibilité et Thérapeutique Immuno-Moléculaire Etablissement de Transfusion Sanguine de Franche-Comté, Besançon. pierre.tiberghien@univ-fcomte.fr
authors.forename: P
authors.initials: P
authors.lastname: Tiberghien
authors.forename: J Y
authors.initials: JY
authors.lastname: Cahn
authors.forename: A
authors.initials: A
authors.lastname: Brion
authors.forename: E
authors.initials: E
authors.lastname: Deconinck
authors.forename: E
authors.initials: E
authors.lastname: Racadot
authors.forename: P
authors.initials: P
authors.lastname: Hervé
authors.forename: N
authors.initials: N
authors.lastname: Milpied
authors.forename: B
authors.initials: B
authors.lastname: Lioure
authors.forename: E
authors.initials: E
authors.lastname: Gluckman
authors.forename: P
authors.initials: P
authors.lastname: Bordigoni
authors.forename: W
authors.initials: W
authors.lastname: Jacob
authors.forename: Y
authors.initials: Y
authors.lastname: Chiang
authors.forename: S
authors.initials: S
authors.lastname: Marcus
authors.forename: C
authors.initials: C
authors.lastname: Reynolds
authors.forename: D
authors.initials: D
authors.lastname: Longo
mesh_terms: D016026:Bone Marrow Transplantation / Q000276:immunology; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D012190:Retroviridae / Q000235:genetics*; D018139:Simplexvirus / Q000201:enzymology*; D013601:T-Lymphocytes / Q000201:enzymology* / Q000637:transplantation; D013937:Thymidine Kinase / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: D013937:Thymidine Kinase